Literature DB >> 23834177

MicroRNAs and cancer therapy - from bystanders to major players.

Cornelia Braicu1, George A Calin, Ioana Berindan-Neagoe.   

Abstract

MicroRNAs (miRNAs) are an evolutionarily conserved class of small regulatory RNAs that modulate gene expression. Extensive research over the last decade has shown that miRNAs are master regulators of cellular processes, with an essential role in cancer initiation, progression, and metastasis. Widespread deregulation of miRNAs in cancers has identified oncogenic and tumor-suppressive roles for these miRNAs. On the basis of these observations, miRNAs have emerged as promising therapeutic tools for cancer management. In this review, we focus on the roles of miRNAs in tumorigenesis, the rationale and strategies for the use of miRNA-based therapy for cancer, and the advantages and current challenges to their use.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23834177     DOI: 10.2174/0929867311320290002

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  25 in total

Review 1.  Nanoscale delivery systems for microRNAs in cancer therapy.

Authors:  Sanda Boca; Diana Gulei; Alina-Andreea Zimta; Anca Onaciu; Lorand Magdo; Adrian Bogdan Tigu; Calin Ionescu; Alexandru Irimie; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

2.  Computational identification and analysis of early diagnostic biomarkers for kidney cancer.

Authors:  Tang Tang; Xiaoyan Du; Xiaoyi Zhang; Wenling Niu; Chunhua Li; Jianjun Tan
Journal:  J Hum Genet       Date:  2019-07-26       Impact factor: 3.172

Review 3.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

4.  Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines.

Authors:  Shohreh Varmeh; Pierre Vanden Borre; Viswanath Gunda; Eran Brauner; Tammy Holm; Yangun Wang; Ruslan Ilyasovich Sadreyev; Sareh Parangi
Journal:  Surgery       Date:  2015-10-09       Impact factor: 3.982

5.  miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.

Authors:  Nahikari Bartolomé-Izquierdo; Virginia G de Yébenes; Angel F Álvarez-Prado; Sonia M Mur; Juan A Lopez Del Olmo; Sergio Roa; Jesus Vazquez; Almudena R Ramiro
Journal:  Blood       Date:  2017-02-10       Impact factor: 22.113

6.  Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology.

Authors:  Emily A Vucic; Kelsie L Thu; Larissa A Pikor; Katey S S Enfield; John Yee; John C English; Calum E MacAulay; Stephen Lam; Igor Jurisica; Wan L Lam
Journal:  BMC Cancer       Date:  2014-10-24       Impact factor: 4.430

Review 7.  The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.

Authors:  Sasha Beyer; Jessica Fleming; Wei Meng; Rajbir Singh; S Jaharul Haque; Arnab Chakravarti
Journal:  Cancers (Basel)       Date:  2017-07-10       Impact factor: 6.639

8.  Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy.

Authors:  Duncheng Wang; Iryna Shanina; Wendy M Toyofuku; Marc S Horwitz; Mark D Scott
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

9.  Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy.

Authors:  Ugur Gezer; Serkan Keskin; Abdullah Iğci; Mustafa Tükenmez; Duygu Tiryakioğlu; Merve Cetinkaya; Rian Dişci; Nejat Dalay; Yeşim Eralp
Journal:  Oncol Lett       Date:  2014-05-28       Impact factor: 2.967

Review 10.  Nanopharmacology in translational hematology and oncology.

Authors:  Ciprian Tomuleasa; Cornelia Braicu; Alexandra Irimie; Lucian Craciun; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.